TESS V3 Modular Total Shoulder System PMCF

Active, not recruitingOBSERVATIONAL
Enrollment

67

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions
Osteoarthritis ShoulderRheumatoid ArthritisRheumatoid Arthritis ShoulderAvascular NecrosisRevisionRotator Cuff TearsOsteonecrosisRotator Cuff Tear ArthropathyProximal Humeral FractureMalunion of Fracture, Shoulder Region
Interventions
DEVICE

Anatomic TESS V3

Implantation of the T.E.S.S.® V3 Modular Total Shoulder System, Anatomic configuration.

DEVICE

Reverse TESS V3

Implantation of the T.E.S.S.® V3 Modular Total Shoulder System, Reverse configuration.

Trial Locations (2)

Unknown

Lyon Ortho Clinic, Lyon

Clinique Saint-Jean (Group ORTHOSUD), Saint-Jean-de-Védas

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY